Advanced Biomed (ADVB) Enterprise Value (2023 - 2026)

Advanced Biomed has disclosed Enterprise Value across 4 years of filings, most recently posting -$2.6 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$2.6 million, up 17.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (up 17.75% YoY), and the FY2025 annual result was -$2.9 million, down 11.42% from the prior year.
• Enterprise Value came in at -$2.6 million for Q1 2026 at Advanced Biomed, roughly flat from -$2.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.6 million in Q2 2024 to a low of -$3.2 million in Q1 2025.
• The 4-year median for Enterprise Value is -$2.7 million (2024), against an average of -$2.7 million.
• Across the five-year window, Enterprise Value slipped 19.25% in 2025 and increased 17.75% in 2026, its largest moves.
• Advanced Biomed's Enterprise Value stood at -$2.8 million in 2023, then advanced by 4.64% to -$2.6 million in 2024, then advanced by 1.13% to -$2.6 million in 2025, then gained by 0.19% to -$2.6 million in 2026.
• The last three Enterprise Value figures came in at -$2.6 million (Q1 2026), -$2.6 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.